The incubation centre of Alexandria, a US-based provider of lab space, at the Genome Valley here would take shape by March.
The company has also proposed a plug-and-play facility and a special economic zone, here. Of this, the plug-and-play facility would be ready in April this year.
These are part of Rs 1,000 crore investments that Alexandria committed to Andhra Pradesh last year.
The Genome Valley set up by the state government on the outskirts of Hyderabad is the first biotech cluster in India for life science research, training and manufacturing activities
Speaking to Business Standard, a government official said the incubation centre would foster start-up companies across the sectors and provide need-based funding to new companies.
The life science infrastructure giant has been allotted 30 acre to create plug-and-play lab space to cater to the needs of domestic and international biotech and pharmaceutical companies.
The SEZ project, being designed for large format pharma and biotechnology companies from the US and other countries keen to set up facilities for research and development in India, would be ready next year, he said, adding the companies would have access to analytical instruments laboratory.
The project is being developed in public private partnership with Alexandria, Department of Biotechnology, CSIR/IICT and the Andhra Pradesh government.
“There is good response from companies to start operations here,” said the official. The high investments in the project would boost the research and development scenario in the country. It would be promoted as a hub for biotechnology, pharma, nano, clean technologies, new materials and other sectors.
He said more facilities would be added depending on the requirements of the companies. It would have a lot of common infrastructure.
